Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) will sell its stake in one of its foreign investments to a US-based company listed on the New York Stock Exchange.
SPIMACO didn’t disclose the name of the concerned investment due to a confidentiality clause, adding that it expects a profit of SAR 150 million from the transaction, which will appear in second quarter financial statements.
The company’s board of directors has already approved the offer, according to its statement to Tadawul.
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}